Alvotech NASDAQ: ALVO said its first-half 2026 results reflected a temporary manufacturing slowdown tied to facility and quality-system improvements at its Reykjavik site, while management reaffirmed full-year revenue and adjusted EBITDA guidance and highlighted upcoming regulatory decisions and product launches. Guidance Reaffirmed as Financing Bolsters Liquidity Alvotech reaffirmed its 2026 guidance for total revenue of $650 million to $700 million and adjusted EBITDA of $180 million to $220 million. Mana ...